Psychotropic and ADHD Drugs: Read the Hemodynamic Profile

Clinical Mastery · Visual teaching summary · October 3, 2026

Andrew Bland, MD, FACP, FAAP

Visual summary

Mental health benefit, adherence, sleep, falls, blood pressure, and electrolytes all contribute to a useful follow-up assessment.

Exposure and signaling can change BP and pulse. See the diagram description and full text below.
· Download full-size illustration (PNG) · Download Markdown · Read text version ·

Illustration updated October 18, 2026. Educational schematic. Imaging and microscopy panels are illustrations, not patient studies. Full teaching text and sources follow.

Diagram description

Exposure and signaling can change BP and pulse. Drug or dose change — Include interacting medicines; Autonomic signaling — Norepinephrine and alpha-2 effects vary; BP and pulse response — Direction depends on the drug and patient; Measured follow-up — Compare with baseline and symptoms. Avoid abrupt unsupported changes; use a drug-specific monitoring and stopping plan. The infographic uses anatomical illustrations and integrated labels; the complete teaching text and evidence are below.

Text version

Map the drug to its main signal

Stimulants and some noradrenergic antidepressants can raise BP or pulse; alpha-adrenergic effects can produce orthostasis; serotonergic agents can contribute to hyponatremia in susceptible patients. Lithium introduces a separate renal-clearance and toxicity problem. Agent and dose matter more than the label psychotropic.

Review the full regimen

Include stimulants, antidepressants, anxiolytics, mood stabilizers, over-the-counter products, and interacting antihypertensives.

Connect symptoms to changes

New dizziness, falls, hypertension, tachycardia, confusion, or sodium abnormalities may follow initiation, dose changes, or acute illness.

Balance competing needs

Do not abandon necessary psychiatric treatment reflexively. Coordinate alternatives, dose adjustments, and monitoring with the prescribing team.

Reassess exposure during kidney change

Review renal dosing, active metabolites, interacting drugs, and hydration when eGFR falls or illness develops. For lithium, confirm level timing and investigate toxicity symptoms promptly. For drugs such as bupropion, small pharmacokinetic studies justify caution but do not establish one universal dialysis dosing schedule.

Monitor function as well as numbers

Mental health benefit, adherence, sleep, falls, blood pressure, and electrolytes all contribute to a useful follow-up assessment.

Continue learning